CHINA'S DRUG REGULATOR ACCEPTS NOVO NORDISK'S APPLICATION FOR ORAL WEGOVY - REUTERS - GNEWS

Regulatory acceptance advances oral Wegovy's EU approval timeline, a key catalyst for Novo Nordisk.